Recruiting NA Bimaxillar Surgery

New treatment option for Bimaxillar Surgery

Official title Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery

ClinicalTrials.gov ID: NCT06933680

What this study is testing

What it's testing
The goal of this clinical trial is to evaluate whether sphenopalatine ganglion (SPG) block helps with intraoperative pain control, reduces postoperative edema, and decreases pain in adults aged 18 to 45 undergoing bimaxillary orthognathic surgery. The main questions it aims to answer are: Does SPG block help decrease postoperative swelling and pain compared to a sham block?

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45

You may be able to join if

  • Patients with bimaxillary orthognathic surgery indication
  • Patients with American Society of Anesthesiologistsscores (ASA) I-II
  • Patients between the ages of 18-45

You likely can't join if

  • Patients with local anesthetic allergy
  • Patients undergoing genioplasty
  • Syndromes associated with secondary deformities in addition to jaw deformities
  • Patients with a history of jaw surgery
  • Patients with uncontrolled hypertension
  • Patients with a history of substance abuse
See the full eligibility criteria
Who can join
  • Patients with bimaxillary orthognathic surgery indication
  • Patients with American Society of Anesthesiologistsscores (ASA) I-II
  • Patients between the ages of 18-45
What rules you out
  • Patients with local anesthetic allergy
  • Patients undergoing genioplasty
  • Syndromes associated with secondary deformities in addition to jaw deformities
  • Patients with a history of jaw surgery
  • Patients with uncontrolled hypertension
  • Patients with a history of substance abuse
  • Patients with chronic pain lasting more than 3 months
  • Patients using analgesic and hypnotic agents for more than 2 weeks
  • Recent situations that may cause facial edema (tooth extraction, facial trauma, etc.)
  • Patients with psychiatric disorders
  • Patients with diabetes mellitus
  • Patients with bleeding disorders

The study team makes the final eligibility decision.

Where it's taking place

  • Istanbul, Fatih, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Istanbul, Fatih, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.